SCHEMBL7364748

SCHEMBL7364748

CCCC[Si](C)(CCO)CCCC

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 3/20 0.41
TSHR P16473 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HSD17B10 Q99714 1/20 0.41
CES2 O00748 4/20 0.33
CES1 P23141 4/20 0.33
NAAA Q02083 1/20 0.31
THRB P10828 1/20 0.31
HTT P42858 1/20 0.31
DNM1 Q05193 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3676139 0.85 TSHR (0.43) ALDH1A1SMN1; SMN2LMNATSHRCES2
SCHEMBL6156565 0.79 TSHR (0.44) ALDH1A1SMN1; SMN2LMNATSHRMEN1
SCHEMBL9034708 0.78 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2LMNATSHRMEN1
Hydrochloric Acid SCHEMBL6878837 0.77 TSHR (0.41) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL2144778 0.77 TSHR (0.50) ALDH1A1LMNATSHRMEN1KMT2A
SCHEMBL14776804 0.76 TSHR (0.47) ALDH1A1SMN1; SMN2LMNATSHRMEN1
SCHEMBL1710460 0.74 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2LMNATSHRMEN1
SCHEMBL13503159 0.74 TSHR (0.33) LMNATSHRTHRB
SCHEMBL13503160 0.74 TSHR (0.33) LMNATSHRTHRB
SCHEMBL5322524 0.74 TSHR (0.33) ALDH1A1LMNATSHRTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0846127-A1 ACYLATED OLIGOPEPTIDE DERIVATIVES HAVING CELL SIGNAL INHIBITING ACTIVITY Novartis AG (CH) 1998-06-10 EP disclosed
EP-0832110-A1 ANTIVIRAL PEPTOID COMPOUNDS Novartis AG (CH) 1998-04-01 EP disclosed
WO-1997008193-A1 ACYLATED OLIGOPEPTIDE DERIVATIVES HAVING CELL SIGNAL INHIBITING ACTIVITY NOVARTIS AG (CH) 1997-03-06 WO disclosed
WO-1997007131-A1 ACYLATED OLIGOPEPTIDES CONTAINING PHOSPHOTYROSINE AS INHIBITORS OF PROTEIN TYROSINE KINASES NOVARTIS AG (CH) 1997-02-27 WO disclosed
WO-1996040759-A1 ANTIVIRAL PEPTOID COMPOUNDS NOVARTIS AG (CH) 1996-12-19 WO disclosed
US-4952690-A 6-substituted thia-aza compounds CIBA-GEIGY CORPORATION (US) 1990-08-28 US disclosed
US-4692442-A ANTIBIOTICS CIBA-GEIGY CORPORATION (US) 1987-09-08 US disclosed
EP-0042026-B1 3,4-DISUBSTITUTED AZETIDIN-2-ON COMPOUNDS AND PROCESS FOR THEIR PREPARATION CIBA-GEIGY AG (CH) 1986-01-08 EP disclosed
US-4524028-A PENICILLINS CIBA-GEIGY CORPORATION (US) 1985-06-18 US disclosed
US-4518533-A Azetidinone-4-disulfides as intermediates for thia-aza compounds with a beta-lactam ring CIBA GEIGY CORPORATION (US) 1985-05-21 US disclosed
US-4515717-A INTERMEDIATES FOR 6-UNSUBSTITUTED PENICILLIN ANTIOBIOTICS CIBA GEIGY CORPORATION (US) 1985-05-07 US disclosed
US-4500457-A TREATING AN ACYLOXYAZETIDINONE WITH MERCAPTO COMPOUND, GLYOYLIC ESTER, HALOGENATION AGENT, AND PHOSPHINE COMPOUNT THEN CYCLIZATION CIBA-GEIGY CORPORATION (US) 1985-02-19 US disclosed
US-4447360-A Intermediates for thia-aza compounds with a β-lactam ring CIBA-GEIGY CORPORATION (US) 1984-05-08 US disclosed
EP-0003960-B1 6-SUBSTITUTED THIA-AZA-COMPOUNDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM CIBA-GEIGY AG (CH) 1983-06-29 EP disclosed
US-4331676-A 2-PENEM COMPOUNDS UNSUBSTITUTED IN THE 6 POSITION CIBA-GEIGY CORPORATION (US) 1982-05-25 US disclosed
EP-0042026-A1 3,4-Disubstituted azetidin-2-on compounds and process for their preparation CIBA-GEIGY AG (CH) 1981-12-23 EP disclosed
EP-0003960-A1 6-Substituted thia-aza-compounds, their preparation and pharmaceutical compositions containing them CIBA-GEIGY AG (CH) 1979-09-19 EP disclosed